{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:51:21Z","timestamp":1769125881624,"version":"3.49.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune polyglandular syndrome (APS) is a group of clinical syndromes resulting from genetic dysfunction of the immune system, affecting multiple endocrine glands as well as non-endocrine organs. Herein, we report a case of APS type 2 (APS-2) in an adult female, characterized predominantly by emaciation, fatigue, palpitations, and notably, refractory hyponatremia. In the late stage of her illness, the patient developed psychiatric abnormalities and was repeatedly hospitalized and treated in neurological facilities; however, no significant abnormalities were detected on relevant examinations. She was subsequently transferred to Guangdong Provincial Hospital of Traditional Chinese Medicine, where a comprehensive endocrine evaluation eventually led to the diagnosis of APS-2. The case was marked by highly non-specific clinical manifestations, which resulted in multiple episodes of misdiagnosis and missed diagnosis throughout her course of treatment. Drawing on the detailed clinical course of this patient and a review of relevant literature, this article analyzes the clinical heterogeneity, diagnostic challenges, and reasons for misdiagnosis associated with APS-2. Furthermore, it highlights the importance of dynamic monitoring of multiple glandular functions, enhancing clinicians\u2019 recognition of this syndrome, and multidisciplinary collaboration to improve patient outcomes and reduce delays caused by misdiagnosis.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1744295","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:55:49Z","timestamp":1769064949000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The \u201cpolyglandular crisis\u201d behind recurrent hyponatremia: misdiagnosis of a case of autoimmune polyglandular syndrome type 2 and clinical lessons learned"],"prefix":"10.3389","volume":"17","author":[{"given":"Manli","family":"Yan","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Meizhou Maternity and Child HealthCare Hospital","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Meizhou Maternity and Child HealthCare Hospital","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyue","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.02.004","article-title":"Autoinmune polyendocrinopathy","volume":"157","author":"Fern\u00e1ndez Mir\u00f3","year":"2021","journal-title":"Med clinica"},{"key":"B2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.autrev.2017.11.012","article-title":"The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)","volume":"17","author":"Guo","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12887-025-05697-3","article-title":"Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"103135","DOI":"10.1016\/j.autrev.2022.103135","article-title":"Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach","volume":"21","author":"Bj\u00f8rklund","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01585-6","article-title":"Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients","volume":"44","author":"Garelli","year":"2021","journal-title":"J endocrinological Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563629","article-title":"Delayed diagnosis of the full triad autoimmune polyendocrine syndrome type 2 with adrenal crisis: a case report and literature review","volume":"16","author":"Yao","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000000235","article-title":"Autoimmune polyglandular syndrome type 2 and recurrent depression","volume":"85","author":"Elsayed","year":"2023","journal-title":"Ann Med Surg (2012)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5603\/ep.107241","article-title":"Lymphocytic colitis as a new disease possibly associated with autoimmune polyendocrine syndrome type 2 (APS-2)","volume":"76","author":"Ziobro","year":"2025","journal-title":"Endokrynol Pol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1606237","article-title":"Autoimmune polyglandular syndrome among Chinese celiac disease patients: a survey of 243 individuals in China","volume":"16","author":"Xue","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"ytac145","DOI":"10.1093\/ehjcr\/ytac145","article-title":"Cardiac tamponade as the initial presentation of autoimmune polyglandular syndrome Type 2: a case report","volume":"6","author":"Glick","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"111333","DOI":"10.1016\/j.mce.2021.111333","article-title":"Beyond classic concepts in thyroid homeostasis: Immune system and microbiota","volume":"533","author":"Fern\u00e1ndez-Garc\u00eda","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1623428","article-title":"Gut-tropic \u03b14\u03b27(+)CD8(+) T cells contribute to pancreatic \u03b2 cell destruction in type 1 diabetes","volume":"16","author":"Su","year":"2025","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1514857","article-title":"A U-shaped non-linear association between serum uric acid levels and the risk of Hashimoto\u2019s thyroiditis: a cross-sectional study","volume":"16","author":"Yan","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13044-025-00254-7","article-title":"Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report","volume":"18","author":"Thomsen","year":"2025","journal-title":"Thyroid Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12902-025-01986-1","article-title":"Risk factors and outcomes of thyroid immune-related adverse events following PD-1\/PD-L1 inhibitors treatment in a large tertiary Chinese center","volume":"25","author":"Gong","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86299","article-title":"Thyroxine reveals Addison\u2019s disease: A case report","volume":"17","author":"Tsinopoulou","year":"2025","journal-title":"Cureus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13224-023-01769-5","article-title":"Adrenal crisis in a patient with autoimmune polyglandular syndrome 2 (APS 2) during pregnancy","volume":"74","author":"Balachandran","year":"2024","journal-title":"J obstetrics gynaecology India"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5603\/ep.107241","article-title":"ymphocytic colitis as a new disease possibly associated with autoimmune polyendocrine syndrome type 2 (APS-2)","volume":"76","author":"Ziobro","year":"2025","journal-title":"Endokrynol Pol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1744295\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:55:51Z","timestamp":1769064951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1744295\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":18,"alternative-id":["10.3389\/fimmu.2026.1744295"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1744295","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"article-number":"1744295"}}